| 產(chǎn)品名稱 | TD52 |
| 產(chǎn)品貨號 | Axon 2700 CAS [1798328-24-1] MF C24H16N4MW 360.41 Purity: 99% Soluble in DMSO Description The CIP2A inhibitor TD52 had more potent apoptotic effects than erlotinib (Axon 1128) in HCC cells (IC50 values of 0.9, 0.9, 0.8 and 1.2 μM in HA22T, Hep3B, PLC5 and Sk-Hep1 cell lines, respectively). Also, CIP2A-dependent p-Akt downregulation mediates TD52-induced apoptosis in TNBC. TD52-induced tumor inhibition was associated with reactivation of PP2A and downregulation of CIP2A and p-Akt in vivo. KEYWORDS: TD52 | supplier | CIP2A inhibitor | TD 52 | TD-52 | CAS [1798328-24-1] | PP2A | CIP2A | Inhibitor | Proteins | p90 | KIAA1524 | HCC | TNBC |
| 產(chǎn)品價格 | 現(xiàn)貨詢價,電話:010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
TD52Axon 2700 CAS [1798328-24-1] MF C24H16N4
DescriptionThe CIP2A inhibitor TD52 had more potent apoptotic effects than erlotinib (Axon 1128) in HCC cells (IC50 values of 0.9, 0.9, 0.8 and 1.2 μM in HA22T, Hep3B, PLC5 and Sk-Hep1 cell lines, respectively). Also, CIP2A-dependent p-Akt downregulation mediates TD52-induced apoptosis in TNBC. TD52-induced tumor inhibition was associated with reactivation of PP2A and downregulation of CIP2A and p-Akt in vivo. KEYWORDS: TD52 | supplier | CIP2A inhibitor | TD 52 | TD-52 | CAS [1798328-24-1] | PP2A | CIP2A | Inhibitor | Proteins | p90 | KIAA1524 | HCC | TNBC
CIP2A inhibitor; Erlotinib derivative
Chemical nameN2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine Parent CAS No.[1798328-24-1] |
| 產(chǎn)品資料 |